Key Pharmacogenomic Considerations for Sickle Cell Disease Patients.
about
Key Pharmacogenomic Considerations for Sickle Cell Disease Patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Key Pharmacogenomic Considerations for Sickle Cell Disease Patients.
@en
type
label
Key Pharmacogenomic Considerations for Sickle Cell Disease Patients.
@en
prefLabel
Key Pharmacogenomic Considerations for Sickle Cell Disease Patients.
@en
P2093
P356
P1476
Key Pharmacogenomic Considerations for Sickle Cell Disease Patients.
@en
P2093
Adamantia Papachatzopoulou
Alexandra Kolliopoulou
Apostolos Stratopoulos
Argyro Sgourou
George P Patrinos
Stavroula Siamoglou
P304
P356
10.1089/OMI.2017.0058
P577
2017-05-09T00:00:00Z